{"id":74620,"date":"2017-12-19T20:42:30","date_gmt":"2017-12-20T04:42:30","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2017\/12\/fda-just-approved-the-first-ever-gene-therapy-for-an-inherited-disease"},"modified":"2017-12-19T20:42:30","modified_gmt":"2017-12-20T04:42:30","slug":"fda-just-approved-the-first-ever-gene-therapy-for-an-inherited-disease","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2017\/12\/fda-just-approved-the-first-ever-gene-therapy-for-an-inherited-disease","title":{"rendered":"FDA Just Approved The First-Ever Gene Therapy For an Inherited Disease"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/fda-just-approved-the-first-ever-gene-therapy-for-an-inherited-disease.jpg\"><\/a><\/p>\n<p>In a historic move, the Food and Drug Administration on Tuesday approved a pioneering gene therapy for a rare form of childhood blindness, the first such treatment cleared in the United States for an inherited disease.<\/p>\n<p>The approval signals a new era for <a href=\"https:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm589197.htm\">gene therapy<\/a>, a field that struggled for decades to overcome devastating setbacks but now is pushing forward in an effort to develop treatments for <a href=\"https:\/\/www.washingtonpost.com\/news\/to-your-health\/wp\/2017\/12\/06\/a-cut-could-have-killed-him-then-he-got-experimental-gene-therapy-for-hemophilia\/\">haemophilia<\/a>, <a href=\"https:\/\/news.harvard.edu\/gazette\/story\/2016\/09\/gene-therapy-for-sickle-cell-disease-passes-key-preclinical-test\/\">sickle-cell anaemia<\/a>, and an array of other genetic diseases.<\/p>\n<p>Yet the products, should they reach patients, are likely to carry <a href=\"https:\/\/www.washingtonpost.com\/business\/economy\/gene-therapies-offer-dramatic-promise-but-shocking-costs\/2015\/11\/11\/01f11cf0-824b-11e5-9afb-0c971f713d0c_story.html\">stratospheric<\/a> prices \u2013 a prospect already worrying consumer advocates and economists.<\/p>\n<p><!-- Link: <a href=\"http:\/\/www.sciencealert.com\/first-fda-gene-therapy-inherited-disease-childhood-blindness\">http:\/\/www.sciencealert.com\/first-fda-gene-therapy-inherited...-blindness<\/a> --><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a historic move, the Food and Drug Administration on Tuesday approved a pioneering gene therapy for a rare form of childhood blindness, the first such treatment cleared in the United States for an inherited disease. The approval signals a new era for gene therapy, a field that struggled for decades to overcome devastating setbacks [\u2026]<\/p>\n","protected":false},"author":413,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-74620","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/74620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/413"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=74620"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/74620\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=74620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=74620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=74620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}